C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 211/22 (2006.01) A61K 31/44 (2006.01) A61P 9/00 (2006.01) A61P 25/00 (2006.01) C07D 211/32 (2006.01) C07F 7/18 (2006.01)
Patent
CA 2374635
The present invention is directed to sulfuric acid mono-[3-({1-[2-(4-fluoro- phenyl)-ethyl]-piperidin-4-yl}-hydroxy-methyl)-2-methoxy-phenyl]ester having the Formula I: Image a metabolite of the 5HT1A antagonist (+)-.alpha.-(2,3-dimethoxyphenyl)-1-[2-(4- fluorophenyl)ethyl]-4-piperidinemethanol and a process for its preparation and its use in the treatment for a number of disease states.
La présente invention concerne un ester d'acide sulfurique mono-[3-({1-[2-(4-fluoro-phényl)-éthyl]-pipéridin-4-yl}-hydroxy-méthyl)-2-méthoxy-phényl], métabolite de l'antagoniste du récepteur de 5HT2A, (+)- alpha -(2,3-diméthoxyphényl)-1-[2-4-fluorophényl)éthyl]-4-pipéridineméthanol, ainsi qu'un procédé de préparation dudit composé et son utilisation dans le traitement d'un certain nombre d'états pathologiques.
Bernotas Ronald Charles
Brown Paul Wayne
Emmons Gary Thomas
King Chi-Hsin Richard
Aventis Holdings Inc.
Aventis Pharmaceuticals Inc.
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Sulfuric acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfuric acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfuric acid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1818041